Website
CSL LimitedTelephone
61.3.9389.1911
Address
655 Elizabeth Street Melbourne, Victoria (VIC) 3000
Description
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 265.14 - 313.55
Trade Value (12mth)
US$31,108,966.00
1 week
0.45%
1 month
1.64%
YTD
-3.3%
1 year
-1.85%
All time high
342.75
EPS 3 yr Growth
4.80%
EBITDA Margin
31.60%
Operating Cashflow
$2,764m
Free Cash Flow Return
10.10%
ROIC
9.70%
Interest Coverage
9.70
Quick Ratio
1.00
Shares on Issue (Fully Dilluted)
486m
HALO Sector
Healthcare
Next Company Report Date
19-Aug-25
Ex Dividend Date (est.)
09-Sep-24
Next Dividend Pay Date (est.)
02-Oct-24
Reporting Currency
USD
Short Sell (% of issue)
0.36
Date | Announcements |
---|---|
19 December 24 |
Change in substantial holding
×
Change in substantial holding |
09 December 24 |
Notification of cessation of securities - CSL
×
Notification of cessation of securities - CSL |
05 December 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
05 December 24 |
Notification regarding unquoted securities - CSL
×
Notification regarding unquoted securities - CSL |
03 December 24 |
Application for quotation of securities - CSL
×
Application for quotation of securities - CSL |
07 November 24 |
Notification of cessation of securities - CSL
×
Notification of cessation of securities - CSL |
05 November 24 |
Notification regarding unquoted securities - CSL
×
Notification regarding unquoted securities - CSL |
05 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
04 November 24 |
Notification regarding unquoted securities - CSL
×
Notification regarding unquoted securities - CSL |
04 November 24 |
Notification of cessation of securities - CSL
×
Notification of cessation of securities - CSL |
30 October 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
29 October 24 |
CSL 2024 AGM Chair and CEO Speech and Presentation
×
CSL 2024 AGM Chair and CEO Speech and Presentation |
29 October 24 |
CSL 2024 AGM Results
×
CSL 2024 AGM Results |
24 October 24 |
Notification regarding unquoted securities - CSL
×
Notification regarding unquoted securities - CSL |
22 October 24 |
Research and Development Investor Briefing
×
Research and Development Investor Briefing |
17 October 24 |
Notice of Research and Development Investor Briefing
×
Notice of Research and Development Investor Briefing |
04 October 24 |
Notification of cessation of securities - CSL
×
Notification of cessation of securities - CSL |
20 September 24 |
Executive Arrangements
×
Executive Arrangements |
18 September 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
12 September 24 |
Update - Dividend/Distribution - CSL
×
Update - Dividend/Distribution - CSL |
10 September 24 |
Application for quotation of securities - CSL
×
Application for quotation of securities - CSL |
09 September 24 |
Notification regarding unquoted securities - CSL
×
Notification regarding unquoted securities - CSL |
06 September 24 |
Notification of cessation of securities - CSL
×
Notification of cessation of securities - CSL |
06 September 24 |
Notification of cessation of securities - CSL
×
Notification of cessation of securities - CSL |
05 September 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.